← All trials
NCT06289673
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2024
- Primary completion
- May 31, 2034
- Completion date
- May 31, 2039
- First posted
- Mar 4, 2024
- Last posted
- Nov 8, 2024
- Enrollment
- 850
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- St. Jude Children's HospitalLead sponsor
- St. Jude Children's HospitalOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.